BPG is committed to discovery and dissemination of knowledge
Editorial
Copyright: ©Author(s) 2026.
World J Diabetes. Aug 15, 2026; 17(8): 115342
Published online Aug 15, 2026. doi: 10.4239/wjd.115342
Figure 1
Figure 1 Overview of the RRM2-PI3K/Akt/Nrf2 pathway in diabetic kidney disease. Reduced RRM2 expression under hyperglycemic conditions promotes ferroptosis and weakens PI3K/Akt/Nrf2 antioxidant defenses, leading to tubular injury and diabetic kidney disease progression. Multiple therapeutic nodes along this axis—including ferroptosis inhibition, antioxidant enhancement, and RRM2 upregulation—represent emerging targets for intervention. ROS: Reactive oxygen species; DKD: Diabetic kidney disease.


Write to the Help Desk